Testing a new drug for severe brain swelling after a large stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new drug called HRS8179 to reduce severe brain swelling after a large stroke. If you have a major stroke on one side of the brain and can start treatment within 10 hours, this study may help prevent dangerous pressure buildup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a large stroke caused by a blocked artery in the middle of the brain on one side.
- Your stroke symptoms are severe (NIHSS score 10 or more).
- Brain scans show a damaged area of about 80 to 160 cubic centimeters.
- You can start the study drug within 10 hours of your stroke or last known well time.
- You do not have signs of severe brain swelling (like a shift in the middle of the brain) or bleeding in the brain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, HRS-4029, given within 3 hours of an ischemic stroke (a stroke caused by a blocked blood vessel). The goal is to see if the drug helps improve recovery.
This trial tests a single dose of a new medicine called HRS-4029 in healthy people. It helps doctors learn how the drug works in the body and if it is safe. Healthy adults aged 18 to 55 may be able to join.
This trial tests a new way to treat ischemic stroke patients who arrive at the hospital 4.5 to 6 hours after symptoms start. It focuses on people eligible for a clot removal procedure, using advanced imaging to see if this approach helps them recover better.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This trial tests a new drug (RK-4) delivered directly through the skull bone to treat patients with large strokes in the brain's main blood vessel. The goal is to see if this approach is safe and can help restore brain function when standard stroke treatments aren't working well enough.
This trial tests a new drug, RK-4, given via injection into the skull for people who have had a major stroke. It's for those who have not improved enough after standard treatment like clot removal.
Hear when a new Severe Cerebral Edema Following Large Hemispheric Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.